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Abstract The number of pregnant women of advanced maternal age has increased worldwide. Women in this group
have an increased chance of fetal abnormality.To explore Japanese women’s experiences regarding maternal
age-specific risks and prenatal testing,we conducted a descriptive qualitative study. Semi-structured interviews
were conducted with 16 women aged 35 years or over who had given birth within the previous three months
to a healthy, term infant. Thematic analysis of transcribed interview data was performed and three major
themes were identified: inadequate understanding of genetic risks; insufficiently informed choice regarding
prenatal testing; and need for more information from health professionals. Some participants were not aware
of maternal age-specific risks to the fetus.Many took their cues from health professionals and did not raise the
topic themselves, but would have considered prenatal testing if made aware of the risks. Nurses, midwives and
other health professionals need to adequately inform pregnant women about the genetic risks to the fetus and
offer testing at an appropriate stage early in the pregnancy.
Key words advancedmaternal age, informed choice, prenatal testing, qualitative study, risk perception, thematic analysis,
fetal abnormality.
INTRODUCTION
Advancedmaternal age (AMA) is defined as 35 years or over
for primipara and 40 years or over for multiparous women at
the time of delivery (International Federation of Gynecology
and Obstetrics, 2014). The number of pregnant women of
AMA has increased worldwide (Laopaiboon et al., 2014). For
example, the proportion of births to women ≥ 35 years in
Japan increased from 8.6% in 1990 to 25.9% in 2012
(Ministry of Health, Labor and Welfare, 2013).This is mainly
attributed to women marrying at an older age than previ-
ously, and advancements in the use of fertility treatments,
including assisted reproductive technology (ART) (Billari
et al., 2011; Ooki, 2013).
Increasing maternal age is associated with a raised inci-
dence of adverse maternal outcomes (Khalil et al., 2013;
Laopaiboon et al., 2014), and women of any parity have an
increased chance of having a babywith a chromosomal abnor-
mality as they age (Nakata et al., 2010; Savva et al., 2010).
Technical progress has brought greater opportunities for ante-
natal screening and testing to detect whether the fetus has an
abnormality (Nakata et al., 2010; Hagen et al., 2011). For five
decades, amniocentesis has been offered, often on the basis of
a woman’s age. In more recent decades, women ≥ 35 years
have had access to antenatal fetal screening using maternal
serum tests and ultrasound beforemaking a decision about an
invasive test (Nakata et al., 2010; Chitty & Bianchi, 2013).
Despite the fact that screening and testing shouldbeoffered as
options rather than routine tests, and that counselling and
information affect the uptake of testing (Godino et al., 2013),
there is still evidence that women and their partners do not
make informed choices (Barr & Skirton, 2013).
In Japan, women concerned about the risks of fetal abnor-
malities can choose non-invasive screening at 10–13 gesta-
tional weeks. In the second trimester, amniocentesis is
offered to women at increased risk of fetal chromosomal
abnormality, that is, women ≥ 35 years at time of delivery
(Genetic-Medicine-Related Societies, 2003). Recently, the
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obstetric clinical setting has changed rapidly as a result of a
obstetrician shortages (Ministry of Health, Labor and
Welfare, 2013) and expanding options for prenatal testing
(Suzumori et al., 2014).
Bayrampour et al. (2012a,b) conducted a qualitative study
of 15 primiparouswomen ofAMA,and identified four themes
related to perception of pregnancy risk: definition of preg-
nancy risk; factors influencing risk perception; risk
alleviation strategies; and risk communication with health
professionals. Yang et al. (2007) studied experiences of
primiparouswomen inAsian countries and reported that their
reactions included surprise and worry about childbirth out-
comes, and embarrassment and ambivalence regarding life-
style changes. In a quantitative study, Yotsumoto et al. (2012)
reported that pregnant women with less knowledge of non-
invasive prenatal testing had a more positive attitude toward
it.However, there are few studies reporting the perceptions of
women of AMA regarding risks related to their age.
In this study, we focused on a particular subset of women
who are at increased risk of bearing a child with a congenital
abnormality.
Study aim
The purpose of this study was to explore the experiences of
mothers regarding maternal age-specific risks and prenatal
testing, within the context of their AMA.
METHODS
Design
This was a descriptive qualitative study using semi-structured
interviews.
Participants
Participants were eligible for inclusion if they were aged 35
years or older and had given birth within the last three
months to a healthy term infant. Purposive sampling was
carried out in order to achieve a maximum variation sample
(Coyne, 1997). An effort was made to recruit women across
the age range of 35–50 years, women who had invasive
testing, as well as those who had not, and women with uncom-
plicated and complicated pregnancies or births.Women were
excluded if: they or their infants had an existing medical
problem after delivery; their infant had been diagnosed with
or was suspected of having a congenital abnormality; or if
they were health professionals.
Data collection
Data were collected using semi-structured interviews, which
is a suitable method for exploratory studies (Polgar &
Thomas, 2008). Prior to the interview, participants’ demo-
graphic information was collected using a short question-
naire. Interviews were then undertaken using a set of open
questions focused on the woman’s pregnancy experience.
The researchers, all of whom have midwifery experience,
designed the interview guide.The major foci of the interview
questions were: (i) given your age when you were pregnant,
did you have any specific concerns about the baby’s health?
and (ii) what information were you given about the chances
that the baby might have Down syndrome or other similar
conditions? Who discussed it with you?
Potential participants were invited to be involved in the
study when they attended a Japanese university hospital
for a routine postnatal check-up one month after birth. The
mother was asked for her permission to be contacted by the
researcher and to have an interview two months after birth.
Sixteen interviews were conducted over nine months during
2011–2012 in quiet, private locations convenient to partici-
pants. Interviews lasted 40–60 mins and 15 interviews were
digitally audio-recorded with the consent of the participant,
with the interviewer taking notes. One interview was not
audio-recorded according to the participant’s wishes.
However, detailed handwritten notes were taken and tran-
scribed almost verbatim immediately after the interview.The
interviewee performed verification of the transcript.We con-
ducted two practice interviews with mothers in the outpatient
clinic to test the interview questions. After these practice
interviews, a question on the information needs of women of
AMA was added because we had obtained little information
on this topic. Interviews ceased when data saturation
occurred.
Data analysis
Interviews were transcribed verbatim, and translated from
Japanese to English by a bilingual researcher, then translated
back into Japanese by another researcher to check that the
translation was correct. Data were analyzed using thematic
analysis described by Braun and Clarke (2006). This induc-
tive approach enabled identified themes to emerge from the
raw data. First, three researchers independently read the
interview transcripts several times to obtain overall impres-
sions. Second, we generated initial codes, which refer to the
most basic elements of the raw data that can be assessed in a
meaningful way. We paid attention to ensure that repeated
patterns within the data were noted for later phases. Third,
we identified a set of subthemes and organized these under
major themes. We then reviewed the themes, identified the
essence of each theme, and named each accordingly. Lastly,
we made a final analysis and selected examples of data to
underpin each theme from the transcripts.
Rigor
Regarding trustworthiness, the interviewer asked partici-
pants questions during and after the interviews to clarify
their perceptions and validate the interpretations of their
intended meanings. To enhance credibility, two experts
checked the two practice interviews. After interviewing,
member checking was performed to confirm the credibility of
the data. One Japanese researcher and two English-speaking
researchers independently analyzed the data at each stage
using the same analysis method. Emergent themes were then
compared. University faculty members and a peer debriefer
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established transferability. Discussion continued until con-
sensus on themes and subthemes was reached and confirmed
by member checking (Holloway & Wheeler, 2009).
Ethical considerations
Ethical approval was obtained from the Institutional Review
Boards of Yamaguchi University Hospital and Yamaguchi
University. Prior to the study, participants were informed of
the study purpose and processes, guaranteed anonymity and
confidentiality by oral and written information, and gave
written informed consent.
RESULTS
The 16 participants had a mean age of 38.1 years (range, 35–
43); nine were primiparous and seven were multiparous. All
were married, and six were employed. Of the 11 participants
who considered their pregnancy to be planned, seven became
pregnant usingART.Nine wished to have another child. One
primiparous mother had undergone amniocentesis during
pregnancy, and one multiparous mother had undergone
amniocentesis in a previous pregnancy (Table 1). The three
emergent themes are described below.
Theme 1: Inadequate understanding of genetic risks
Most participants were aware that the risk of fetal congenital
anomaly increased with maternal age; however,many did not
understand the risks in detail:
It may have been due to my age, but I had two concerns,
one is my physical matters (sic) and the other is whether
my baby would be born with a handicap or not in this
second pregnancy . . . I was most worried about if my
baby has normal fingers and feet or no heart problem
because I had got a lot of information about risk to the
fetus with advanced maternal age from elsewhere.
(Participant 5)
Participants recognized the connection between their age
and pregnancy risks by hearing the word kourei ninshin,
referring to a woman who gives birth at ≥ 35 years.This label
triggered women’s anxiety about the risks. Some participants
felt that they might have additional risks if they were > 40
years. Additionally, some participants who had conceived
using ART were worried about additional genetic risk to the
fetus because of the use of this method. However, some were
surprised at their high-risk status:
I think that micro-insemination is done by hand using an
injection needle. I am not an expert in this area so I was
really worried that there was some risk involved, or
that there might be some problems with the baby . . .
(Participant 3)
When I was first examined at a clinic, I was told to go to
the university hospital because I was a primiparous
advanced maternal age woman . . . I didn’t even go into
the exam room. I was very shocked. (Participant 12)
However, a few participants did not know that the risk to
the fetus increased with maternal age. Two multiparous
mothers believed the risks ofAMAwere only associated with
primiparous pregnancies and many multiparous women
mentioned that they were not given information during this
pregnancy:
I only heard that Down syndrome [is] caused by
increased maternal age after delivery of this child [third
Table 1. Demographic characteristics of the women in the study
Participant no. Age (years) Parity Using ART Desire for another child Return to full-time work Pregnancy complication
1 38 3 – No No –
2 37 1 ICSI Yes Yes PIH
3 37 1 ICSI Yes No –
4 36 4 – No No Threatened miscarriage
5 40 2 IVF No No –
6 37 1 ICSI Yes Yes Threatened miscarriage
7 39 1 – Yes Yes Threatened miscarriage & had
amniocentesis
8 43 2 – No No –
9 39 1 – No No PIH, asthma, threatened premature
labor
10 39 1 ICSI Yes No Myoma
11 36 2 AIH No No Threatened miscarriage
12 41 1 – Yes Yes –
13 39 1 – Yes Yes –
14 37 1 – Yes Yes Placenta praevia
15 35 2 AIH Yes No –
16 36 3 – No No Threatened premature labor
AIH, artificial insemination with husband’s sperm;ART, assisted reproductive technology; ICSI, intracytoplasmic sperm injection; IVF, in vitro
fertilization; PIH, pregnancy-induced hypertension.
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child]. I had never heard of it before then. When [I
transferred to a university hospital, and] I gave birth and
heard about it for the first time, and was like, what is all
this about? (Participant 1)
I do not know how being old is increases the risk to the
baby. I think it also depends on whether or not it’s your
first child. I think whether or not you’ve had a miscar-
riage before . . . but I don’t really know for sure. (Par-
ticipant 2)
Theme 2: Insufficiently informed choice for
prenatal testing
Subtheme 1: Recognition for invasive testing
Regarding testing, some participants were aware of the mis-
carriage risk associated with amniocentesis and believed
testing did not provide a definite result. On the other hand,
some participants knew nothing about testing and some were
given information about testing or obtained it too late for
termination of pregnancy:
I didn’t know that there are many tests of genetic screen-
ing before I watched it on the TV. Unless I had said
something, the doctor probably wouldn’t say anything,
would they? . . . When I found out on TV that amnio-
centesis was possible, it was too late. On the other hand,
without TV, I would probably have never known. (Par-
ticipant 5)
Subtheme 2: Ambivalent feelings and inferring risks to
the fetus
Many participants would have continued with the pregnancy
even if the fetus had an abnormality and were, thus, dis-
suaded from testing. While many women were ambivalent
about testing, they were reassured and/or made their own
calculations of risk, based on ultrasound screening:
When thinking of having a test, if I found my baby was
abnormal from the test . . . when I think about what I
would have done with the baby, then I think “I would
rather not know” . . . I’m not sure if I could raise the
child even if it is born, but what is most difficult is being
asked to choose. (Participant 5)
I could guess the risks of my pregnancy personally, and
asked my doctor “Isn’t my baby pretty small?” because
my first baby was stillborn and I was quite nervous. But
the doctor didn’t worry about my baby. . . . In the ultra-
sound up until the amniocentesis there was no abnor-
mality with the size, and all I could do was believe in the
child. (Participant 10)
Subtheme 3: Couples’ decision-making process
In the decision-making process, some participants discussed
testing with their husband. Some then had an amniocentesis
because they wanted to know as much as possible and do
what was best for the baby:
While reading the book, it mentioned lots of different
things. I realized it would be a problem if the baby had a
disability, so I discussed it with my husband. I was con-
cerned about a disability with my baby, but really the
only thing we could do was amniocentesis, but . . . we
decided to do whatever we could, and I had the test.The
test didn’t show any abnormalities, so I was able to be
reassured about those aspects . . . I think that helped me
through my pregnancy. (Participant 7)
However, some made individual choices and/or withheld
information from their husbands:
My husband seemed to want to do the testing for con-
genital abnormalities, but didn’t know what it involved
in detail. When he came to the check-up with me, he
asked the doctor about it directly, but we were told that
it was already “too late.” Although I already knew, I
didn’t say anything because I felt sorry for the baby.
Either way, I would have wanted to have the baby if the
baby was disabled. (Participant 9)
Theme 3: Need for more information from
health professionals
Subtheme 1: Interaction with health professionals
Many participants reported they had received no informa-
tion from health professionals. In some cases, information
was only given by a health professional if the mother asked a
direct question:
I wondered if I would have explanations of the risks and
tests. I thought I shouldn’t worry since I was told no
problem of my pregnancy. But, I did wonder if there
would be any explanations. (Participant 13)
Many participants appear to have been reassured by
doctors telling them that the baby was healthy.They believed
that if an abnormality were suspected, their doctor would
mention it. They were, therefore, reassured by the lack of
information provided about risks or tests:
I just have read about it [amniocentesis] through books
and the Internet . . . I thought maybe I would be told to
have the test, but I was not. So I thought I must be OK.
(Participant 14)
Doctors sometimes actively discouraged women to have
testing, such as amniocentesis:
When I said that, my doctor told me “Everyone asks
about the tests hoping that their own child won’t have
any problems, but if they did, have you thought about
what you would do?” and“If there was a problem,would
you terminate the pregnancy?” So I was a bit startled by
that. After that, the reaction from the hospital was like
“Well, we don’t really support terminating a pregnancy
for that reason.” I thought a lot about it but decided that
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maybe it was better not to know, and in the end I didn’t
do the testing. (Participant 2)
Subtheme 2: Information needs
Many participants reported ambivalence about obtaining
information, because too much information might increase
worry. In fact, some participants consciously resisted obtain-
ing information. Furthermore, some women appeared to feel
obliged to have tests performed if the doctor actively men-
tioned it:
Well, if my doctor had told me about the test maybe that
would have caused me to be anxious anyway, so I think
for me it was better that they didn’t talk to me about it.
. . . but I do wish a little bit that the doctor had spoken to
me about amniocentesis. (Participant 3)
. . . I know a mother who was still thinking of having the
test, so if the doctor explains about the test, she would
decide to have it . . . They may think it is kind of
obligatory. If the doctor said so, I had better [do it] . . .
(Participant 15)
Mothers stressed that the decision should be made without
any type of coercion. However, they wished to obtain at least
minimal information about testing because without this they
would not know what to question. Therefore, they wished to
have written information, such as pamphlets or books to
read, and, subsequently, raise the issue with health profes-
sionals themselves if they wished:
Even if I was told to ask, I think that some people who
would not know how to ask. I think that if at [the] least
information is provided, then anxiety would be eased. I
think that depending on the person, as expected there
are people who obtain information and those who don’t
know how to ask . . . I think if we got told a little then it
would be helpful for pregnant women. (Participant 11)
In addition, women wished to talk about the risk of the
pregnancy and/or testing with their “own” doctors and mid-
wives.A lack of opportunity for discussion with their midwife
or doctor often led to an inability to make an informed
choice:
If I need to know something, I’d rather hear it from a
specialist doctor than from the Internet or the TV, so I’d
like the doctor to tell me everything I need to know . . .
Rather than worrying myself with the talk of people who
don’t know anything about it, I’d rather worry myself
with what I have been told directly by a specialist. My
baby is healthy now, so I think maybe it was OK that I
didn’t ask, but if things hadn’t gone well then I’d prob-
ably wish I’d asked about it. (Participant 3)
DISCUSSION
Our findings highlight the experiences of women of AMA
in relation to risks to the fetus and prenatal testing. These
experiences are important because they affect prenatal care
use, information seeking and decision-making about prenatal
testing.
Risk perception of women of advanced medical age
Many participants recognized that there were risks of having
a baby with a congenital anomaly, such as Down syndrome,
that were connected with maternal age; this finding reflected
those of previous studies (Maheshwari et al., 2008;
Bayrampour et al., 2012a,b).On the other hand, some women
did not fully recognize the extent of the risk – this was espe-
cially true of multiparous women. This might be because
women who conceive at an older age may feel fortunate to
conceive and are, thus, unwilling to consider testing or termi-
nation. It has been shown that information about risk may
increase anxiety rather than alleviate concerns (Carolan &
Nelson, 2007), and this may lead women to limit information-
seeking to avoid such anxiety (Bayrampour et al., 2012a,b).
Furthermore, some women were worried about additional
risks to the fetus if they conceived usingART.Misperception
of the risks may either lead women to seek higher levels of
medical intervention because they incorrectly perceive them-
selves as being high risk, based on their age alone (Cooke
et al., 2010), or to be ignorant of their high-risk status
(Carolan & Nelson, 2007; Carolan & Frankowska, 2011). To
promote the empowerment of women, health professionals
should be sensitive to the fact that women may not be aware
of all of the risks associated with maternal age, and provide
appropriate information, such as the fact that maternal age
itself does not involve noticeable extra risk for non-
chromosomal birth defects (Ooki, 2013). Pre-conception
education and risk communication will benefit women, as
suggested in a previous study (Cooke et al., 2010).
Informed choice and decision-making
Our findings support the idea that women of AMA have
ambivalent feelings about seeking information since they
might aware of pregnancy risks. Similar to previous findings
(Cooke et al., 2012), some of the women in our study would
have liked to have known the status of their fetus, but would
have continued the pregnancy even if the fetus was affected
by a condition; thus, they were dissuaded from testing.
On the other hand, many participants were given little
information by health professionals and in many cases were
only provided with information once they had asked for it.
Women expressed a wish for individual face-to-face discus-
sions with their health professionals about “their own” risks,
but this may not have been offered because of limitations
on pregnancy termination and restrictions on discussion of
screening in the past. In Japan, the guideline for screening
using serummarkers (Ministry of Health, Labor andWelfare,
1999) recommends that doctors need not actively explain this
and should not actively recommended it to pregnant women.
Termination may be conducted only before the gestation age
at which the fetus would be viable outside the womb. This is
usually prior to 22 weeks gestation (JAOG, 1990). However,
it is not legal to terminate a pregnancy at any time because of
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fetal abnormalities. Therefore, doctors may refrain from
explaining prenatal testing because, if they find a fetal abnor-
mality, they cannot terminate pregnancy for that reason.As a
result of the expansion of genetic counselling services in
2011, the national guideline now requires those considering
the maternal serum marker test to have adequate and suffi-
cient genetic counselling (Guideline for NIPT, 2013). While
technical progress has brought greater opportunities, the
legal and social systems continue to present challenges,which
need to be discussed nationally.
In addition, culture may influence the discussion of topics
such as disability. In Japan, serious illness is still not always
discussed between care provider and patient, and some
patients prefer not to know if their illness is life threatening
or incurable (Turale & Ito, 2008). Moreover, some women in
our study believed that the baby was a blessing and that
parents have the potential to look after a child if he/she is
born with a disability.While some participants preferred not
to have an amniocentesis, they wanted ultrasound screening.
However, they may have been unaware that soft markers
(minor anatomical variants detected on ultrasound) can
indicate a risk that the fetus has a chromosomal abnormal-
ity, such as Down syndrome (Holmgren & Lacoursiere,
2008). Furthermore, many of our participants believed that
if the fetus had a suspected abnormality, the doctor would
have mentioned it and recommended prenatal testing. These
misunderstandings might hinder accurate informed consent
for prenatal testing. Health professionals should pay atten-
tion to these aspects of prenatal testing and informed
consent.
While some participants discussed prenatal testing with
their husbands, many participants made their own choices.
Sharing the decision-making process represents a possible
cause of conflict between the woman and her husband
(Arimori, 2006;Durand et al., 2010).Therefore,women might
take responsibility for their own decisions during pregnancy.
In Japan, some women and their partners believe in tradi-
tional gender role ideology, that is, “a man’s job is to earn
money and a woman’s job is to look after the home and
family” (Cooke et al., 2012). However, work by Barr and
Skirton (2013) in the United Kingdom has shown that while
fathers wish to be involved in decision-making, nurses/
midwives make little effort to include partners in discussions
about prenatal screening (Suplee et al., 2007). Further
research is needed on the role of the partner in the decision-
making process in Japan and other countries.
Information needs and nursing care
Although they expressed a need for “adequate” information,
many participants felt they had been over-informed regard-
ing the pregnancy, which reflects findings of previous studies
(Carolan, 2007). Therefore, most participants sought useful
information, given sensitively and unobtrusively. This finding
is consistent with studies of women in the UK (Barr &
Skirton, 2013). Both the volume and method in which infor-
mation is delivered influences the decisions of a woman and
her partner.
Limitations
In this study, participants were sampled from only one hos-
pital; therefore, it is not clear if the findings are transferable
to other settings. However, the experiences and beliefs of
women from an eastern country such as Japan may be impor-
tant not only in the East, but in Western countries with mul-
ticultural populations. Future research is needed using
triangulation methods, such as collecting data from partners
or health professionals, to obtain more data across a wider
population.
CONCLUSION
While some of our participants recognized maternal age-
specific risks to the fetus, others were unaware of such risks.
A lack of awareness of these risks could result in uninformed
decision-making and decisional conflicts between women
and healthcare providers. It is important that health profes-
sionals consider women’s informational needs, taking into
account cultural and religious influences. Nurses, midwives,
and doctors, in particular, must take more responsibility for
providing adequate information and access to appropriate
counselling regarding possible genetic issues. Further
research to explore the most effective way of sensitively pro-
viding adequate information is required.
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